Skip links

{excerpt1]}

Read < 1 minute

India and Kenya have inked two agreements in the field of agriculture during Kenyan President Uhuru Kenyatta’s visit to New Delhi.The agreements were signed after wide-ranging bilateral talks with Indian Prime Minister Narendra Modi.

Modi said the two nations were collaborating to raise agricultural productivity in Kenya adding that Kenyatta and his delegation’s participation in the global investors’ summit, Vibrant Gujarat, would encourage industry and businesses in both nations.

The meeting helped Kenya to secure a KSh10 billion loan from India to improve agricultural productivity, with President Uhuru Kenyatta also asking for India’s help to train more medical practitioners adding that Kenya heavily relies on the generic ARVs drugs manufactured in India, for HIV infected patients.

“India’s exchange of health services is globally acknowledged. Many of our country men and women travel to India every year. Advanced technology, coupled with price competitiveness makes your country a preferred destination for thousands of Kenyans seeking quality healthcare. I did request the PM for further scholarships in areas such as medicine, pharmacy, dentistry and ICT, which are relevant to our National government priority areas,” he said.

Moreover, President Uhuru lauded India’s initiative to offer scholarships and training opportunities for Kenyans especially in medicine and pharmacy.

“The establishment of a cancer hospital and provision of treatment, equipment supported by the Indian government is greatly anticipated as it will go a long way to ensure quality affordable treatment,” he said.

At the same time, The PM emphasized that the expansion of bilateral trade, greater flow of capital between the two economies and stronger development partnerships are cornerstones for stronger ties.

Both nations however, expect to exploit opportunities in healthcare, tourism, information technology, agriculture, blue economy and energy.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish.